Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Strongyloides Autoinfection Manifesting as Larva Currens in an Immunocompetent Patient.

Drago F, Ciccarese G, Brigati C, Parodi A.

J Cutan Med Surg. 2016 Nov;20(6):617-618. No abstract available.

PMID:
27821543
2.

Epigenetic Silencing of DKK3 in medulloblastoma.

Valdora F, Banelli B, Stigliani S, Pfister SM, Moretti S, Kool M, Remke M, Bai AH, Brigati C, Hielscher T, Romani M, Servidei T, Zollo M, Cinalli G, Oberthuer A, Tonini GP, Coco S.

Int J Mol Sci. 2013 Apr 8;14(4):7492-505. doi: 10.3390/ijms14047492.

3.

HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.

Di Vinci A, Brigati C, Casciano I, Banelli B, Borzì L, Forlani A, Ravetti GL, Allemanni G, Melloni I, Zona G, Spaziante R, Merlo DF, Romani M.

Transl Res. 2012 Nov;160(5):355-62. doi: 10.1016/j.trsl.2012.05.007. Epub 2012 Jun 23.

PMID:
22735029
4.

Toward an epigenetic view of our musical mind.

Brigati C, Saccuman MC, Banelli B, Di Vinci A, Casciano I, Borzì L, Forlani A, Allemanni G, Romani M.

Front Genet. 2012 Jan 11;2:111. doi: 10.3389/fgene.2011.00111. eCollection 2011.

5.

A pyrosequencing assay for the quantitative methylation analysis of the PCDHB gene cluster, the major factor in neuroblastoma methylator phenotype.

Banelli B, Brigati C, Di Vinci A, Casciano I, Forlani A, Borzì L, Allemanni G, Romani M.

Lab Invest. 2012 Mar;92(3):458-65. doi: 10.1038/labinvest.2011.169. Epub 2011 Dec 12.

6.

Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome.

Di Vinci A, Casciano I, Marasco E, Banelli B, Ravetti GL, Borzì L, Brigati C, Forlani A, Dorcaratto A, Allemanni G, Zona G, Spaziante R, Gohlke H, Gardin G, Merlo DF, Mantovani V, Romani M.

J Cancer Res Clin Oncol. 2012 Jan;138(1):35-47. doi: 10.1007/s00432-011-1070-5. Epub 2011 Sep 27.

PMID:
21947269
7.

Inflammation, HIF-1, and the epigenetics that follows.

Brigati C, Banelli B, di Vinci A, Casciano I, Allemanni G, Forlani A, Borzì L, Romani M.

Mediators Inflamm. 2010;2010:263914. doi: 10.1155/2010/263914. Epub 2010 Dec 19. Review.

8.

Epigenetic mechanisms regulate ΔNP73 promoter function in human tonsil B cells.

Brigati C, Banelli B, Casciano I, Di Vinci A, Matis S, Cutrona G, Forlani A, Allemanni G, Romani M.

Mol Immunol. 2011 Jan;48(4):408-14. doi: 10.1016/j.molimm.2010.09.001. Epub 2010 Dec 3.

PMID:
21129776
9.

Circulating Tumor Nucleic Acids: Perspective in Breast Cancer.

Casciano I, Vinci AD, Banelli B, Brigati C, Forlani A, Allemanni G, Romani M.

Breast Care (Basel). 2010;5(2):75-80. Epub 2010 Apr 23.

10.

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.

Banelli B, Bonassi S, Casciano I, Mazzocco K, Di Vinci A, Scaruffi P, Brigati C, Allemanni G, Borzì L, Tonini GP, Romani M.

Int J Cancer. 2010 Feb 1;126(3):656-68. doi: 10.1002/ijc.24768.

11.

Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.

Di Vinci A, Sessa F, Casciano I, Banelli B, Franzi F, Brigati C, Allemanni G, Russo P, Dominioni L, Romani M.

Int J Oncol. 2009 Feb;34(2):449-56.

PMID:
19148480
12.

Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target.

Albini A, Brigati C, Ventura A, Lorusso G, Pinter M, Morini M, Mancino A, Sica A, Noonan DM.

J Transl Med. 2009 Jan 14;7:5. doi: 10.1186/1479-5876-7-5.

13.

The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes.

Albini A, Benelli R, Noonan DM, Brigati C.

Int J Dev Biol. 2004;48(5-6):563-71. Review.

14.

DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemias.

Ferrari N, Palmisano GL, Paleari L, Basso G, Mangioni M, Fidanza V, Albini A, Croce CM, Levi G, Brigati C.

J Leukoc Biol. 2003 Aug;74(2):302-5.

PMID:
12885948
15.

Induction of apoptosis by fenretinide in tumor cell lines correlates with DLX2, DLX3 and DLX4 gene expression.

Ferrari N, Paleari L, Palmisano GL, Tammaro P, Levi G, Albini A, Brigati C.

Oncol Rep. 2003 Jul-Aug;10(4):973-7.

PMID:
12792755
16.

HIV Tat, its TARgets and the control of viral gene expression.

Brigati C, Giacca M, Noonan DM, Albini A.

FEMS Microbiol Lett. 2003 Mar 14;220(1):57-65. Review.

17.

Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis.

Benelli R, Morini M, Brigati C, Noonan DM, Albini A.

Int J Oncol. 2003 Jan;22(1):87-91.

PMID:
12469189
18.

Tumors and inflammatory infiltrates: friends or foes?

Brigati C, Noonan DM, Albini A, Benelli R.

Clin Exp Metastasis. 2002;19(3):247-58. Review.

PMID:
12067205
19.

Tissue inhibitors of metalloproteases: regulation and biological activities.

Fassina G, Ferrari N, Brigati C, Benelli R, Santi L, Noonan DM, Albini A.

Clin Exp Metastasis. 2000;18(2):111-20. Review.

PMID:
11235986
20.
21.

A retinoic acid resistant HL-60 cell clone sensitive to N-(4-hydroxyphenyl) retinamide-mediated clonal growth inhibition.

Brigati C, Ferrari N, Megna M, Roncella S, Cutrona G, Tosetti F, Vidali G.

Leuk Lymphoma. 1995 Mar;17(1-2):175-80.

PMID:
7773156
22.

An improved RT-PCR protocol for the quantitation of human retinoic acid receptor RNA.

Ferrari N, Pfeffer U, Tosetti F, Brigati C, Vidali G.

Exp Cell Res. 1994 Mar;211(1):121-6.

PMID:
7510246
23.

An essential yeast gene encoding a TTAGGG repeat-binding protein.

Brigati C, Kurtz S, Balderes D, Vidali G, Shore D.

Mol Cell Biol. 1993 Feb;13(2):1306-14.

24.

Regulation of plasma retinol binding protein secretion in human HepG2 cells.

Tosetti F, Ferrari N, Pfeffer U, Brigati C, Vidali G.

Exp Cell Res. 1992 Jun;200(2):467-72.

PMID:
1315290
25.
26.

Diffuse interstitial lung disease associated with hypersensitivity to gold salt.

Bellelli A, Boiardi L, Tumiati B, Brigati C.

Clin Exp Rheumatol. 1985 Apr-Jun;3(2):181-2. No abstract available.

PMID:
3926364
27.
28.

Altered expression of B lymphocyte surface immunoglobulins in minimal change nephrotic syndrome and focal glomerulosclerosis.

Dall'Aglio P, Meroni PL, Barcellini W, Brigati C, Chizzolini C, De Bartolo G, Migone L, Zanussi C.

Nephron. 1984;37(4):224-8.

PMID:
6611510
29.

[Immunologic studies in uremia].

Dall'Aglio P, Chizzolini C, Brigati C, Ghiringhelli P.

Minerva Nefrol. 1983 Apr-Jun;30(2 Suppl):19-26. Italian. No abstract available.

PMID:
6602955
30.

Minimal change glomerulonephritis and focal glomerulosclerosis markers and 'in vitro' activity of peripheral blood mononuclear cell.

Dall'Aglio P, Chizzolini C, Brigati C.

Proc Eur Dial Transplant Assoc. 1983;19:673-8.

PMID:
6348758

Supplemental Content

Loading ...
Support Center